RecruitingPhase 3NCT04267848Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])Sponsor: National Cancer Institute (NCI)Camden, NJ · Moorestown, NJ · Mount Holly, NJ · +1147 more sites
RecruitingPhase 2 / Phase 3NCT06712316Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)Sponsor: BioNTech SEEast Brunswick, NJ · Florham Park, NJ · Paramus, NJ · +50 more sites
RecruitingPhase 3NCT06119581A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerSponsor: Eli Lilly and CompanyParamus, NJ · +86 more sites
RecruitingPhase 1 / Phase 2NCT04486833Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on OsimertinibSponsor: Genprex, Inc.Paramus, NJ · +9 more sites